Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.

Rubin, Rita

Rubin, Rita.

JAMA ; 329(12): 963-964, 2023 03 28.

Article in English | MEDLINE | ID: covidwho-2278953

This Medical News Q&A discusses research highlights from the recent Conference on Retroviruses and Opportunistic Infections.

Subject(s)

Antiviral Agents; COVID-19 Drug Treatment; HIV Infections; Post-Exposure Prophylaxis; Protease Inhibitors; Humans; Anti-HIV Agents/therapeutic use; Antiviral Agents/therapeutic use; COVID-19; Goals; HIV Infections/prevention & control; HIV Infections/transmission; Opportunistic Infections; Protease Inhibitors/therapeutic use; Retroviridae; Sexually Transmitted Diseases/prevention & control; Post-Exposure Prophylaxis/methods; COVID-19 Drug Treatment/methods; Patient-Centered Care

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Protease Inhibitors / HIV Infections / Post-Exposure Prophylaxis / COVID-19 Drug Treatment Limits: Humans Language: English Journal: JAMA Year: 2023 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google